High materiality7/10
ProMIS Neurosciences initiated with a Buy at Chardan
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Chardan Capital initiates PMN with a Buy rating; Target price $20; posted price $12.20.
- Chardan Buy target $20 vs price $12.20
Key facts
- 01
Target: $20
- 02
Posted price: $12.2
- 03
Analyst firm: Chardan Capital
- 04
Analyst: Keay Nakae
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.